Patent Expiry
BBIO: NULIBRY: recorded patent 7504095 expiry
April 9, 2029 · FOSDENOPTERIN HYDROBROMIDE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- April 9, 2029
- Company
- BridgeBio Pharma, Inc. (BBIO)
- Drug
- FOSDENOPTERIN HYDROBROMIDE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
NULIBRY: recorded patent 7504095 expiry
Orange Book application NDA214018, product 001, listed patent 7504095 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- FOSDENOPTERIN HYDROBROMIDE